Search

everythinglearnresearchcommunity

for

Search:↓

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Stem cell research and regenerative medicine have made significant advancements in treating various diseases and conditions.

The visfatin GT genotype may increase the risk of Alopecia Areata.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

Beard and scalp hair cells have different gene expressions, which may affect beard growth characteristics.

Placental cell medium boosts blood vessel growth in lab tests.

Certain plasma proteins and genes are linked to obstructive sleep apnea, suggesting potential new treatments.

Hair follicles play a crucial role in regulating skin barrier function.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

New therapies like JAK inhibitors and stem cells show promise in treating vitiligo.

Inhibiting IL-17 and IL-23 improves wound healing in obese, diabetic mice by promoting healing macrophages.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

RXRα is crucial for proper immune response and links diet to immune function.

Hormones like testosterone and estrogen significantly affect hair growth and structure.

People with atopic dermatitis have different skin bacteria, and targeting these bacteria might help treat the condition.

Dupilumab helped a 13-year-old regrow hair after alopecia totalis.

LED light therapy at 863 nm wavelength can slow down skin tumor growth and reduce inflammation in mice.

Certain plant extracts may help prevent hair loss and promote hair growth safely.

Developing human skin has immune cells with memory-like features.

Promising treatments for EBS include anti-inflammatory drugs, antibiotics, creams, mTOR inhibitors, and gene editing, but more trials are needed.

PCOS causes inflammation regardless of body weight.

Cepharanthine may help treat COVID-19 by targeting similar pathways as other inflammatory diseases.

Bullous pemphigoid is influenced by genetic factors, immune cell dysfunction, aging, and triggers, with treatment often improving symptoms.

Biologics and small molecules can effectively treat inflammatory nail disorders, but personalized treatment plans are important.

A combination of ixekizumab and tofacitinib successfully treated severe scalp cellulitis, leading to hair regrowth.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.